Listed

Relmada Therapeutics, Inc.

RLMDNasdaqCIK 1553643HealthcareFiscal year ends Dec 31

Reports and events: 239 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Relmada Therapeutics, Inc., Reports and events
FiledFormWhat it isAccession number
2021-05-1216:01 ET10-QQuarterly reportPeriod 2021-03-310001213900-21-025786
2021-03-3117:00 ETDEF 14AProxy statementPeriod 2021-05-200001213900-21-019299
2021-03-2417:30 ET10-KAnnual reportPeriod 2020-12-310001213900-21-017556
2021-03-2316:29 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001213900-21-017294
2021-03-1517:16 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001213900-21-015427
2021-03-1517:14 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001213900-21-015425
2021-01-0708:15 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001213900-21-000805
2021-01-0516:01 ET8-K5.02 Departure or appointment of officers or directors0001213900-21-000428
2020-12-1417:12 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001213900-20-042571
2020-12-0816:18 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001213900-20-041596
2020-11-1608:56 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001213900-20-037155
2020-11-1216:14 ET10-QQuarterly reportPeriod 2020-09-300001213900-20-036542
2020-10-2716:54 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001213900-20-033559
2020-08-1217:01 ET10-QQuarterly reportPeriod 2020-06-300001213900-20-021649
2020-06-0309:28 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001213900-20-013981
2020-05-1517:25 ET10-QQuarterly reportPeriod 2020-03-310001213900-20-012693
2020-04-0616:30 ET8-K/A5.02 Departure or appointment of officers or directors0001213900-20-008650
2020-03-1216:27 ET8-K1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001213900-20-006126
2020-03-0916:17 ET8-K1.01 Entry into a material agreement; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits0001213900-20-005746
2020-01-3116:27 ETDEF 14AProxy statementPeriod 2020-03-060001213900-20-002274
2020-01-1016:15 ET8-K1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001213900-20-000758
2019-12-2608:00 ET8-K5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits0001213900-19-026923
2019-12-0616:06 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001213900-19-025518
2019-12-0316:03 ET8-K1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits0001213900-19-025202
2019-11-1317:01 ET10-QQuarterly reportPeriod 2019-09-300001213900-19-023219
2019-10-2116:20 ET8-K7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001213900-19-020718
2019-10-1816:10 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001213900-19-020604
2019-10-1717:05 ETS-1/ARegistration statement, amended0001213900-19-020561
2019-10-1116:23 ETS-1/ARegistration statement, amended0001213900-19-020211
2019-10-0116:19 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001213900-19-019395
2019-09-2712:28 ET8-K3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits0001213900-19-019122
2019-09-2415:48 ET10-KAnnual reportPeriod 2019-06-300001213900-19-018787
2019-08-1217:27 ETS-1Registration statement0001213900-19-015376
2019-07-2916:56 ET8-K1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001213900-19-013905
2019-07-1811:00 ET8-K/A8.01 Other events; 9.01 Financial statements and exhibits0001213900-19-013065
2019-07-1716:41 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001213900-19-012991
2019-06-2016:40 ET8-K1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits0001213900-19-011141
2019-05-1518:16 ET10-QQuarterly reportPeriod 2019-03-310001213900-19-008633
2019-04-1516:29 ET8-K1.01 Entry into a material agreement; 5.03 Amendment to articles or bylaws0001213900-19-006397
2019-02-2816:48 ET8-K5.07 Shareholder vote results0001213900-19-003330
2019-02-2616:45 ETS-1/ARegistration statement, amended0001213900-19-003153
2019-02-1317:21 ET10-QQuarterly reportPeriod 2018-12-310001213900-19-002391
2019-02-1108:00 ET8-K1.01 Entry into a material agreement0001213900-19-002029
2019-01-1417:29 ETS-1Registration statement0001213900-19-000697
2019-01-0916:10 ETDEF 14AProxy statementPeriod 2019-02-270001213900-19-000461
2019-01-0417:10 ET8-K1.01 Entry into a material agreement; 1.02 Termination of a material agreement0001213900-19-000223
2018-12-1016:30 ET8-K1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits0001213900-18-017152
2018-11-1315:39 ET10-QQuarterly reportPeriod 2018-09-300001213900-18-015476
2018-11-0817:00 ET8-K1.01 Entry into a material agreement; 3.02 Unregistered sale of equity0001213900-18-015176
2018-10-1816:35 ET8-K1.01 Entry into a material agreement; 3.02 Unregistered sale of equity0001213900-18-014088

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 13, 2026, 15:42 ET. Listed shows no prices and gives no investment advice.